POINT Biopharma, A Wholly Owned Subsidiary Of Eli Lilly And Company
United States
Member Since:Jan 31, 2024
Ownership:N/A
Number of Offices:N/A
Total Employees:51-200
Established In:2019
POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer
No record available!
No record available!
No record available!
No record available!
No record available!
No record available!